2-Acetamino-1,2-dideoxynojirimycin-lysine hybrids as hexosaminidase inhibitors.

[1]  S. Withers,et al.  1-Deoxygalactonojirimycin-lysine hybrids as potent D-galactosidase inhibitors. , 2008, Bioorganic & medicinal chemistry.

[2]  E. Brown,et al.  Identification of Pharmacological Chaperones for Gaucher Disease and Characterization of Their Effects on β‐Glucocerebrosidase by Hydrogen/Deuterium Exchange Mass Spectrometry , 2008, Chembiochem : a European journal of chemical biology.

[3]  S. Withers,et al.  Glycosidase profiling with immobilised glycosidase-inhibiting iminoalditols--a proof-of-concept study. , 2008, Bioorganic & medicinal chemistry letters.

[4]  S. Withers,et al.  Iminoalditol-amino acid hybrids: synthesis and evaluation as glycosidase inhibitors. , 2007, Carbohydrate research.

[5]  D. Voehringer,et al.  Chitin induces accumulation in tissue of innate immune cells associated with allergy , 2007, Nature.

[6]  T. Stockley,et al.  Pyrimethamine as a Potential Pharmacological Chaperone for Late-onset Forms of GM2 Gangliosidosis* , 2007, Journal of Biological Chemistry.

[7]  S. Withers,et al.  High-throughput screening for human lysosomal beta-N-Acetyl hexosaminidase inhibitors acting as pharmacological chaperones. , 2007, Chemistry & biology.

[8]  K. Sandhoff,et al.  Sphingolipid metabolism diseases. , 2006, Biochimica et biophysica acta.

[9]  S. Withers,et al.  Fluorescent glycosidase inhibiting 1,5-dideoxy-1,5-iminoalditols. , 2006, Bioorganic & medicinal chemistry letters.

[10]  S. Withers,et al.  Fluorescently tagged iminoalditol glycosidase inhibitors as novel biological probes and diagnostics. , 2006, Bioorganic & medicinal chemistry.

[11]  Chi‐Huey Wong,et al.  Synthesis and high-throughput screening of N-acetyl-beta-hexosaminidase inhibitor libraries targeting osteoarthritis. , 2004, The Journal of organic chemistry.

[12]  G. Hart,et al.  O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. McDonnell,et al.  A general synthesis of iminosugars. , 2004, Journal of Organic Chemistry.

[14]  S. Withers,et al.  Pharmacological Enhancement of β-Hexosaminidase Activity in Fibroblasts from Adult Tay-Sachs and Sandhoff Patients* , 2004, Journal of Biological Chemistry.

[15]  N. Asano.  Naturally occurring iminosugars and related compounds: structure, distribution, and biological activity. , 2003, Current topics in medicinal chemistry.

[16]  W. Schmid,et al.  Timely research perspectives in carbohydrate chemistry , 2002 .

[17]  Stephen G. Withers,et al.  Biochemical and Structural Assessment of the 1-N-Azasugar GalNAc-isofagomine as a Potent Family 20 β-N-Acetylhexosaminidase Inhibitor* , 2001, The Journal of Biological Chemistry.

[18]  M. Lotz,et al.  Hexosaminidase inhibitors as new drug candidates for the therapy of osteoarthritis. , 2001, Chemistry & biology.

[19]  S. Withers,et al.  Powerful probes for glycosidases: novel, fluorescently tagged glycosidase inhibitors. , 2001, Bioorganic & medicinal chemistry letters.

[20]  S. Withers,et al.  Crystallographic Evidence for Substrate-assisted Catalysis in a Bacterial β-Hexosaminidase* , 2001, The Journal of Biological Chemistry.

[21]  G. Hart,et al.  Carbohydrates in chemistry and biology , 2000 .

[22]  M. Lotz,et al.  Profile of glycosaminoglycan-degrading glycosidases and glycoside sulfatases secreted by human articular chondrocytes in homeostasis and inflammation. , 2000, Arthritis and rheumatism.

[23]  K. Sandhoff,et al.  Sphingolipids-Their Metabolic Pathways and the Pathobiochemistry of Neurodegenerative Diseases. , 1999, Angewandte Chemie.

[24]  A. Vasella,et al.  Recent Insights into Inhibition, Structure, and Mechanism of Configuration-Retaining Glycosidases. , 1999, Angewandte Chemie.

[25]  A. Stütz.  Iminosugars as Glycosidase Inhibitors , 1998 .

[26]  R. Furneaux,et al.  Syntheses of the fungicide/insecticide allosamidin and a structural isomer , 1994 .

[27]  W. Szarek,et al.  A new practical synthesis of (2S,3R,4R,5S)-3,4-dihydroxy-2,5-bis(hydroxymethyl)pyrrolidine , 1993 .

[28]  E. Lüllau,et al.  Bovine N-acetyl-beta-D-glucosaminidase: affinity purification and characterization of its active site with nitrogen containing analogs of N-acetylglucosamine. , 1991, Biochimica et biophysica acta.

[29]  G. Legler,et al.  Synthesis and Inhibitory Properties of 2-Acetamido-2-Deoxynojirimycin (2-Acetamido-5-amino-2,5-dideoxy- D -glucopyranose, 1) and 2-Acetamido-1,2-dideoxynojirimycin (2-Acetamido-1,5-imino-1,2,5-trideoxy- D -Glucitol, 2) , 1989 .

[30]  D. Mahuran,et al.  The subunit and polypeptide structure of hexosaminidases from human placenta. , 1980, Canadian journal of biochemistry.

[31]  L. Hough,et al.  Nucleophilic replacement reactions of sulphonates : Part VIII. Methyl 2-benzamido-2-deoxy-6-O-tosyl-α-D-glucopyranoside, and its conversion into 6-deoxy and other derivatives , 1972 .